Benzinga | Nov 1, 2021 08:05AM EDT

Kiniksa Pharmaceuticals Q3 EPS $(0.44) Beats $(0.65) Estimate, Sales $12.10M Beat $10.18M Estimate

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.65) by 32.31 percent. This is a 33.33 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $12.10 million which beat the analyst consensus estimate of $10.18 million by 18.86 percent.